return to the Course index

previous | next

If we use F • DOSE for Xg^{0} where F is the fraction of the dose
absorbed, the integrated equation for Cp *versus* time is shown in Equation 8.3.1.

**Equation 8.3.1 Drug Concentration after an Oral Dose**

Notice that the right hand side of this equation (Equation 8.3.1) is a constant multiplied by the difference of two exponential terms. **A biexponential equation**.

We can plot Cp as a constant times the difference between two exponential curves (see Figure 2.2.1). If we plot each exponential separately.

**Figure 8.3.1 Linear Plot of e ^{-k' x t} versus Time for Two Exponential Terms**

Notice that the difference starts at zero, increases, and finally decreases again toward a value of zero.

**Plotting this difference multiplied by**
gives Cp

**Figure 8.3.2 Linear Plot of Drug Concentration versus Time**

We can calculate the plasma concentration at anytime if we know the values of all the parameters of Equation 8.3.1.

The parameters CL, kel and V are dependent on the drug and the patient. Different patients will have different values for CL, kel and V. This might depend on their age, weight, sex, genetic make-up (pharmacogenomics) and/or state of health. Different drugs can have quite different values of CL, kel and V.

While dose is clearly a parameter associated with the dosage form, the parameters F and ka are partly determined by the drug and patient and also by the dosage form or route of administration. The rate (ka) and extent (F) of absorption can depend on the drug and patient with respect to transfer from the site of administration to the blood stream. The value of F may be reduced by poor solubility, drug instability, metabolism by intestinal flora, metabolism or reverse transport by various enzyme systems. The value of ka will be influenced by the drug dissolution rate and ability of the drug to move across any barriers between the site of administration and the blood stream. Both F and ka can also be influenced by the drug dosage form. Generally F is maximize but reduced values of ka may be desired to produce a sustained release effect.

**Equation 8.3.2 Time of Peak Concentration after an Oral Dose**, t_{peak} or t_{max}

As an example we could calculate the peak plasma concentration given that F = 0.9, Dose = 600 mg, ka = 1.0 hr^{-1}, kel = 0.15 hr^{-1}, and V = 30 liter.

Using Equation 8.3.2

and now using Equation 8.3.1 we can calculate Cp_{peak} or Cp_{max} for a single oral dose

As another example we could consider what would happen with ka = 0.2 hr^{-1} instead of 1.0 hr^{-1}

Using Equation 8.3.2

and now using Equation 8.3.1 we can calculate Cp_{peak} or Cp_{max} for a single oral dose

Note the peak drug concentration is lower and slower with the smaller ka value.

**Equation 8.3.3 Laplace of Amount in the Body/Plasma (Xp) where kel = ka = k**

Equation 8.3.3 was converted to an equation for amount versus time, Equation 8.3.4, using the Laplace table provided by Mayersohn and Gibaldi (1970).

**Equation 8.3.4 Amount of drug in plasma, Xp, versus time**

Rearranging gives an equation for concentration versus time, Equation 8.3.5.

**Equation 8.3.5 Concentration of drug, Cp, versus time, where kel = ka**

Equation 8.3.5 was used when calculating concentration versus time for simulations when ka = kel. The time of maximum concentration, t_{peak}, can be calculated with Equation 8.3.6, derived by setting dX/dt = 0 = k • Xg - k • Xp (Equation 8.2.3) and substituting in values for Xg (= F • Dose • e^{-k • t}) and Xp (= F • Dose • k • t • e^{-k • t}).

**Equation 8.3.6 Time of maximum concentration, t _{peak}, versus time, where kel = ka**

- Mayersohn, M. and Gibaldi, M. 1970 "Mathematical Methods in Pharmacokinetics. I. Use of the Laplace Transform in Solving Differential Rate Equations,"
*Amer. J. Pharm. Ed.*,**34**:608-614

return to the Course index

previous | next

This page was last modified: Wednesday, 5th Sep 2018 at 4:53 pm

Privacy Statement - 25 May 2018

Material on this website should be used for Educational or Self-Study Purposes Only

iBook and pdf versions of this material and other PK material is available

Copyright © 2001-2021 David W. A. Bourne (david@boomer.org)